Pediatr. praxi. 2020;21(4):259-263 [Dermatol. praxi. 2020;14(3):118-122]

The role of dermocosmetics in acne treatment

MUDr. Zuzana Nevoralová, Ph.D.
Akné poradna, Kožní oddělení Nemocnice Jihlava

The importance of dermocosmetics in acne treatment shows an increasing role. Dermocosmetics can be used for several reasons: for a management of side effects, for a synergystic role with an acne therapy and for a preventive and maintenance therapy. An appropriate chosen camouflage cosmetics and fotoprotection are of a great importance, too. Various types of active compounds can affect different targets: an abnormal sebum production, an abnormal keratinization, a microbioma and an inflammation, alone or in combination. Dermocosmetics can be used in monotherapy, or in combination with drugs. If well choosed, it can help a lot in the treatment of acne. And on contrary, an inappropriate chosen and wrong used it can even worsen acne. In the article, the possibilities of dermocosmetics use and their active compounds and preparations are described.

Keywords: acne, dermocosmetics, effective compounds.

Published: September 3, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoralová Z. The role of dermocosmetics in acne treatment. Pediatr. praxi. 2020;21(4):259-263.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Nevoralová Z. Léčba acne vulgaris. Postgraduální medicína 2013; 15: 209-216.
    2. Gollnick HPM, et al. A consensus‑based practical and daily guide for the treatment of acne patients. J EurAcad Dermatol Venereol 2016; epub. Doi: 0.1111/jdv.13675.
    3. Nevoralová Z. Léčba akné. In: Nevoralová Z, Rulcová J, Benáková N. Obličejové dermatózy, 2. přepracované a doplněné vydání. Mladá fronta 2018; 74.
    4. Araviiskaia E, Estebaranz JLL. Dermocosmetics: beneficial adjuncts in the treatment of acne vulgaris. J Dermatol Treatment. [on‑line] [2019-07-05]. Go to original source... Go to PubMed...
    5. Aravilskaia E, Dreno B. The role of topical dermocosmetics in acne vulgaris. J Eur Acad Dermatol Venereol 2016; 30: 926-935. Go to original source... Go to PubMed...
    6. Draelos ZD, Ertel KD, Berge CA. Facilitating facial retinization through barrier improvement. Cutis 2006; 78: 275-281. Go to PubMed...
    7. Laquieze S, Czernielewski J, Rueda MJ. Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne. J Drugs Dermatol 2006; 5: 985-990. Go to PubMed...
    8. Isoda K, Seki T, Inoue Y, et al. Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin. J Dermatol 2015; 42: 181-188. Go to original source... Go to PubMed...
    9. Kligman A. Results of a pilot study evaluating the compatibility of topical tretinoin in combination with glycolic acid. Cosmet Dermatol 1993; 6: 28-32.
    10. Elson ML. Differential effects of glycolic acid and tretinoin in acne vulgaris. Cosmet Dermatol 1992; 5: 36-40.
    11. Nevoralová Z. Udržovací léčba akné. Dermatol. praxi 2016; 10(1): 10-15. Go to original source...
    12. Draelos ZD. Cosmetics and Cleansers in Acne. In: Zoubolis CH, Katsambas AD, Kligman AM. Pathogenesis and Treatment of Acne and Rosacea. Springer‑Verlag Berlin Heidelberg 2014; 503-508. Go to original source...
    13. Baran R, Chivot M, Shalita A. Acne. In: Baran R, Maibach H, eds. Textbook of Cosmetic Dermatology, 2nd edn. Martin Dunitz, London, 1998: 433-438.
    14. Dréno B, Castell A, Tsankov N, et al. Interest of the association retinaldehyde/glycolic acid in adult acne. J Eur Acad Dermatol Venereol 2009; 23: 529-532. Go to original source... Go to PubMed...
    15. Poli F, Ribet V, Lauze C, et al. Efficacy and safety of 0.1% retinaldehyde/6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double‑blind, randomized, vehicle‑controlled trial. Dermatology 2005; 210(Suppl. 1): 14-21. Go to original source... Go to PubMed...
    16. Green BA, Yu RJ, Van Scott EJ. Clinical and cosmeceutical uses of hydroxyacids. Clin Dermatol 2009; 27: 495-501. Go to original source... Go to PubMed...
    17. Abels C, Kaszuba A, Michalak I, et al. A 10% glycolic acid containing oil‑in‑water emulsion improves mild acne: a randomized double‑blind placebo‑controlled trial. J Cosmet Dermatol 2011; 10: 202-209. Go to original source... Go to PubMed...
    18. Bissonnette R, Bolduc C, Seité S, et al. Randomized study comparing the efficacy and tolerance of a lipophilic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris. J Cosmet Dermatol 2009; 8: 19-23. Go to original source... Go to PubMed...
    19. Baumann LS, Oresajo C, Yatskayer M, et al. Comparison of clindamycin 1% and benzoyl peroxide 5% gel to a novel composition containing salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, and dioic acid in the treatment of acne vulgaris. J Drugs Dermatol 2013; 12: 266-269. Go to PubMed...
    20. Morel P, Vienne MP, Beylot C, et al. Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris. Clin Exp Dermatol 1999; 24: 354-357. Go to original source... Go to PubMed...
    21. Dréno B, Nocera T, Verrière F, et al. Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti‑acne treatments in 1,709 patients. Dermatology 2005; 210(Suppl. 1): 22-29. Go to original source... Go to PubMed...
    22. Letawe C, Boone M, Piérard GE. Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol 1998; 23: 56-58. Go to original source... Go to PubMed...
    23. Benáková N, Nevoralová Z, Rulcová J. AKNÉ Informace a rady pro pacienty. Informační leták.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.